Back to Search

SUJITH KALMADI, MD

MD

Hematology & Oncology Physician

NPI: 1508973447IndividualAccepts Medicare

Specialties, Licenses & Credentials

Hematology & Oncology PhysicianPrimary

Internal Medicine — Hematology & Oncology

Code: 207RH0003X

38208(AZ)

Education

OTHER

Class of 1993

Research & Publications (10)

Clinical utility of temozolomide in the treatment of malignant paraganglioma: a preliminary report.
PMID 19536732·Horm Metab Res·2009
5-case
Evolving perspectives of the role of novel agents in androgen-independent prostate cancer.
PMID 19468458·Indian J Urol·2008
8-other
Gemcitabine and cisplatin in unresectable malignant mesothelioma of the pleura: a phase II study of the Southwest Oncology Group (SWOG 9810).
PMID 18006112·Lung Cancer·2008
3-trial
Lenalidomide: the emerging role of a novel targeted agent in malignancies.
PMID 17353946·Drugs Today (Barc)·2007
6-review
Neoadjuvant therapy for hepatocellular carcinoma: is there an optimal approach?
PMID 17910314·Oncology (Williston Park)·2007
6-review
Phase I trial of three-weekly docetaxel, carboplatin and oral lenalidomide (Revlimid) in patients with advanced solid tumors.
PMID 17103043·Invest New Drugs·2007
3-trial
Phase II trial of weekly docetaxel and gemcitabine as first-line therapy for patients with advanced non-small cell lung cancer.
PMID 17303909·Med Oncol·2006
3-trial
Epsilon aminocaproic acid reduces transfusion requirements in patients with thrombocytopenic hemorrhage.
PMID 16708357·Cancer·2006
8-other
The emerging role of arsenic trioxide as an immunomodulatory agent in the management of multiple myeloma.
PMID 16809883·Acta Haematol·2006
6-review
Inhibition of either phosphatidylinositol 3-kinase/Akt or the mitogen/extracellular-regulated kinase, MEK/ERK, signaling pathways suppress growth of breast cancer cell lines, but MEK/ERK signaling is critical for cell survival.
PMID 16187238·Breast Cancer Res Treat·2005
8-other

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Address
695 S DOBSON RD
CHANDLER, AZ 85224

Location

Practice Location

695 S DOBSON RD, CHANDLER, AZ
(480) 821-2838

Quick Facts

NPI
1508973447
Entity Type
Individual
Gender
Male
Medicare
Accepted
Specialties
1
Locations
1
Years in Practice
33
Publications
10

Are you this provider?

Claim Your Profile